ATE397005T1 - Sialyl-lewisa und sialyl-lewisx epitope analoge - Google Patents

Sialyl-lewisa und sialyl-lewisx epitope analoge

Info

Publication number
ATE397005T1
ATE397005T1 AT97901068T AT97901068T ATE397005T1 AT E397005 T1 ATE397005 T1 AT E397005T1 AT 97901068 T AT97901068 T AT 97901068T AT 97901068 T AT97901068 T AT 97901068T AT E397005 T1 ATE397005 T1 AT E397005T1
Authority
AT
Austria
Prior art keywords
sialyl
lewisa
lewisx
epitope analogue
epitope
Prior art date
Application number
AT97901068T
Other languages
English (en)
Inventor
Reinhold Oehrlein
Original Assignee
Glycomimetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomimetics Inc filed Critical Glycomimetics Inc
Application granted granted Critical
Publication of ATE397005T1 publication Critical patent/ATE397005T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04Disaccharides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97901068T 1996-01-30 1997-01-17 Sialyl-lewisa und sialyl-lewisx epitope analoge ATE397005T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH22996 1996-01-30

Publications (1)

Publication Number Publication Date
ATE397005T1 true ATE397005T1 (de) 2008-06-15

Family

ID=4182238

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97901068T ATE397005T1 (de) 1996-01-30 1997-01-17 Sialyl-lewisa und sialyl-lewisx epitope analoge

Country Status (6)

Country Link
US (1) US6187754B1 (de)
EP (1) EP0886639B1 (de)
AT (1) ATE397005T1 (de)
AU (1) AU1444697A (de)
DE (1) DE69738731D1 (de)
WO (1) WO1997028174A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060189547A1 (en) 2000-04-12 2006-08-24 Christian Samuel T Novel pharmaceutical agents containing carbohydrate moieties and methods of their preparation and use
US7345031B2 (en) 2000-04-12 2008-03-18 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use
US6548484B1 (en) * 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
US9302982B2 (en) 2000-04-12 2016-04-05 Glycon Llc Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use
FR2827599A1 (fr) * 2001-07-20 2003-01-24 Neuro3D Composes derives de quinoleine et quinoxaline,preparation et utilisations
FI20011664A7 (fi) * 2001-08-17 2003-02-18 Carbion Oy Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
AU2003249641B2 (en) 2002-05-16 2009-08-20 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
JP2006502986A (ja) * 2002-07-03 2006-01-26 グリコミメティクス, インコーポレイテッド 新脈管形成に関与する医学的状態の診断および治療のための組成物および方法
AU2003301209A1 (en) * 2002-12-20 2004-07-22 Glycomimetics, Inc. Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
US7361644B2 (en) * 2003-11-19 2008-04-22 Glycomimetics, Inc. Specific antagonist for both E- and P-selectins
EP1685145A2 (de) * 2003-11-19 2006-08-02 GlycoMimetics, Inc. Glycomimetische antagonisten von sowohl e- als auch p-selektinen
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
JP5175190B2 (ja) * 2005-08-09 2013-04-03 グリコミメティクス, インコーポレイテッド シュードモナス由来のpa−ilレクチン、pa−iilレクチンまたは両方のレクチンのグリコミメティック阻害剤
US7728117B2 (en) 2005-09-02 2010-06-01 Glycomimetics, Inc. Heterobifunctional pan-selectin inhibitors
US20090176717A1 (en) * 2006-06-01 2009-07-09 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
EP2074132B1 (de) 2006-10-12 2013-05-15 GlycoMimetics, Inc. Glycomimetischer ersatz für hexosen und n-acetyl-hexosamine
EP2457573A1 (de) * 2007-02-09 2012-05-30 GlycoMimetics, Inc. Verfahren zur Verwendung von Glykomimetika für Hexosen und N-Acetyl-Hexosamine
US8039442B2 (en) * 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en) * 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
CA2727788A1 (en) * 2008-06-13 2009-12-17 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
US8410066B2 (en) * 2009-05-01 2013-04-02 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
US8343971B2 (en) * 2009-09-15 2013-01-01 Rutgers, The State University Of New Jersey Pharmacologically-active vanilloid carbamates
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
SI2794626T1 (en) 2011-12-22 2018-02-28 Glycomimetics, Inc. E-SELECTINE ANTAGONIST COMPOUNDS
GB201214736D0 (en) 2012-08-17 2012-10-03 Isis Innovation Inflammation imaging and therapy
LT2928476T (lt) 2012-12-07 2018-05-25 Glycomimetics, Inc. Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai
HUE045542T2 (hu) 2014-12-03 2019-12-30 Glycomimetics Inc E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
WO2017127422A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (de) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Kombination von t-zell-checkpoint-inhibitoren mit e-selectin- oder cxcr4-inhibitoren oder mit heterobifunktionellen e-selectin- wie auch cxcr4-inhibitoren
CA3037850A1 (en) 2016-10-07 2018-04-12 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (de) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Verfahren zur mobilisierung von knochenmarkinfiltrierenden lymphozyten und deren verwendung
EP3732186A1 (de) 2017-12-29 2020-11-04 GlycoMimetics, Inc. Heterobifunktionale inhibitoren von e-selektin und galectin-3
US11707474B2 (en) 2018-03-05 2023-07-25 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925796A (en) * 1986-03-07 1990-05-15 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
SE9301677L (sv) * 1993-05-14 1994-11-18 Kurt G I Nilsson Syntesmetod
RO117533B1 (ro) * 1993-05-14 2002-04-30 Cytel Corp San Diego DERIVATI DE ANALOGI SIALIL LeX INHIBITORI AI ADEZIUNII CELULARE SI COMPOZITIE FARMACEUTICA CU ACESTIA

Also Published As

Publication number Publication date
EP0886639A1 (de) 1998-12-30
EP0886639B1 (de) 2008-05-28
AU1444697A (en) 1997-08-22
WO1997028174A1 (en) 1997-08-07
DE69738731D1 (de) 2008-07-10
US6187754B1 (en) 2001-02-13

Similar Documents

Publication Publication Date Title
DE69738731D1 (de) SIALYL-LEWISa UND SIALYL-LEWISx EPITOPE ANALOGE
DE69737496D1 (de) SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE
ES2101499T3 (es) Fibras.
MX9709351A (es) Derivados de alfa-hordotionina con alto contenido de treonina.
PL316658A1 (en) Novel application of serotonin antagonists
MX9709352A (es) Derivados de alfa-hortodionina con alto contenido de metionina.
FI962200A0 (fi) Resonoiva mikrosoninen synteesi
AU2266297A (en) Recovery of taxanes from conifers
MY131298A (en) 5-heteroyl indole derivatives
AU3738597A (en) Molecular model for vla-4 inhibitors
ES2184127T3 (es) Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad.
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
ES2182906T3 (es) Grapa quirurgica helicoidal.
ES2163573T3 (es) Copolimeros de esteres de poliaminoacidos.
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE59005097D1 (de) Verwendung härtbarer Cycloaliphaten-Derivate in Dübelmassen.
ES2088076T3 (es) Piperacinil- y piperidinilciclohexanoles.
FI952797A0 (fi) D-vitamiinianalogin uusi kiteinen muoto
NO975557L (no) Immortalisering og dissimortalisering av celler
ZA9710796B (en) Oxyiminopregnanecarbolactones.
ATE294152T1 (de) Substituierte tetrahydro-naphtaline und analoge verbindungen
NO990497L (no) Modifiserte oligosakkarider
AR016981A2 (es) Polipeptidos sinteticos
ES2167748T3 (es) Derivados del polisacarido k5 con actividad anticoagulante.
DE59100670D1 (de) Bausatz zur herstellung von büro-arbeitstischen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties